Valuation: Pathkey.AI Ltd

Market Cap 4.13Cr 2.87Cr 2.51Cr 2.32Cr 2.14Cr 4.06Cr 273.85Cr 28Cr 11Cr 134.91Cr 11Cr 11Cr 463.78Cr P/E 2024
-1.36x
P/E 2025 -3.77x
Enterprise Value 4.13Cr 2.87Cr 2.51Cr 2.32Cr 2.14Cr 4.06Cr 273.68Cr 28Cr 11Cr 134.83Cr 11Cr 11Cr 463.5Cr EV / Sales 2024
9.78x
EV / Sales 2025 21.1x
Free-Float
59.45%
Yield 2024 *
-
Yield 2025 -
1 day-4.17%
1 week-22.03%
Current month-32.35%
1 month-20.69%
3 months+100.00%
6 months+170.59%
Current year+187.50%
1 week 0.04
Extreme 0.045
0.06
1 month 0.04
Extreme 0.045
0.08
Current year 0.02
Extreme 0.016
0.08
1 year 0.01
Extreme 0.014
0.08
3 years 0.01
Extreme 0.014
0.08
5 years 0.01
Extreme 0.014
0.2
10 years 0.01
Extreme 0.014
3.4
Manager TitleAgeSince
Chief Tech/Sci/R&D Officer - 17/01/1994
Chief Executive Officer - 11/05/2026
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Chairman - 21/10/2025
Director/Board Member - 21/10/2025
Chairman - 26/11/2025
Change 5-day change 1-year change 3-year change Capi.($)
-4.17%-22.03%+119.05%-8.00% 2.03Cr
+0.22%-1.36%-31.09%-8.06% 3.09TCr
-0.03%-7.75%-37.79%+203.85% 1.43TCr
-0.77%-4.53%-21.60%+70.12% 564.42Cr
-3.61%-4.45% - - 230.44Cr
-1.47%+4.39%+56.57%-38.76% 204.29Cr
-8.87%-17.72% - - 183.64Cr
0.00%-4.32%-29.71% - 109.24Cr
-6.61%-1.44%+51.42%+111.45% 95Cr
+0.60%+0.69%-32.76%+253.47% 83Cr
Average -2.46%-5.73%+9.26%+83.44% 599.25Cr
Weighted average by Cap. -0.50%-3.23%-27.18%+60.40%

Financials

2024 2025
Net sales 4L 3L 2L 2L 2L 4L 2.64Cr 26.66L 10.47L 1.3Cr 10.38L 10.16L 4.47Cr 3L 2L 2L 2L 2L 3L 2.14Cr 21.59L 8L 1.05Cr 8L 8L 3.62Cr
Net income -31.3L -21.77L -19.05L -17.57L -16.22L -30.79L -21Cr -2.1Cr -82.43L -10Cr -81.75L -79.97L -35Cr -14.48L -10.07L -9L -8L -8L -14.24L -9.6Cr -97.07L -38.12L -4.73Cr -37.81L -36.99L -16Cr
Net Debt -4L -3L -2L -2L -2L -4L -2.49Cr -25.12L -10L -1.22Cr -10L -10L -4.21Cr -25.17T -17.5T -15.31T -14.12T -13.04T -24.75T -16.69L -2L -66.26T -8L -65.72T -64.29T -28.27L
Logo Pathkey.AI Ltd
Pathkey.AI Ltd, formerly Opyl Limited, is an artificial intelligence (AI) company. The Company leverages data and technology to transform the landscape of clinical trials and medical research. It is a digital health company specializing in leveraging artificial intelligence technologies to elevate clinical trial design and forecast outcomes, empowering clinical researchers, biopharmaceutical corporations, and medical investors to enhance trial design, drug development, and market delivery. Its Social Media Insights solution captures and analyses online public conversations from people living with a medical condition, healthcare professionals, carers, and researchers. Its TrialKey platform provides users access to tailored and actionable steps to address critical trial challenges. The Company specializes in applying AI and predictive analytics to social media to accelerate therapy adoption and market development in the healthcare industry.
Employees
-
Date Price Change Volume
13/26/13 A$0.0460 -4.17% 25,44,466
10/26/10 A$0.0480 -2.04% 15,46,722
09/26/09 A$0.0490 -9.26% 15,87,084
08/26/08 A$0.0540 -3.57% 38,23,558
07/26/07 A$0.0560 -5.08% 27,56,984